Allergy Therapeutics (LSE:AGY) Short-Term Debt : £0.64 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Allergy Therapeutics Short-Term Debt?

Allergy Therapeutics's Short-Term Debt for the quarter that ended in Dec. 2023 was £0.64 Mil.

Allergy Therapeutics's quarterly Short-Term Debt declined from Dec. 2022 (£0.78 Mil) to Jun. 2023 (£0.65 Mil) and declined from Jun. 2023 (£0.65 Mil) to Dec. 2023 (£0.64 Mil).

Allergy Therapeutics's annual Short-Term Debt declined from Jun. 2021 (£0.96 Mil) to Jun. 2022 (£0.95 Mil) and declined from Jun. 2022 (£0.95 Mil) to Jun. 2023 (£0.65 Mil).

Allergy Therapeutics Short-Term Debt Historical Data

The historical data trend for Allergy Therapeutics's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Short-Term Debt Chart

Allergy Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Short-Term Debt

Get a 7-Day Free Trial

0.69

0.83

0.96

0.95

0.65

Allergy Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Debt	Get a 7-Day Free Trial															1.01	0.95	0.78	0.65	0.64

Allergy Therapeutics Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Allergy Therapeutics Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Allergy Therapeutics (LSE:AGY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergy Therapeutics PLC (LSE:AGY) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

HHU:Germany

Address

Dominion Way, Worthing, West Sussex, GBR, BN14 8SA

Website

https://www.allergytherapeutics.com

Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics (LSE:AGY) Headlines

No Headlines